EP1546176A4 - Methods and compositions concerning altered yellow fever virus strains - Google Patents

Methods and compositions concerning altered yellow fever virus strains

Info

Publication number
EP1546176A4
EP1546176A4 EP03765574A EP03765574A EP1546176A4 EP 1546176 A4 EP1546176 A4 EP 1546176A4 EP 03765574 A EP03765574 A EP 03765574A EP 03765574 A EP03765574 A EP 03765574A EP 1546176 A4 EP1546176 A4 EP 1546176A4
Authority
EP
European Patent Office
Prior art keywords
altered
methods
fever virus
yellow fever
virus strains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03765574A
Other languages
German (de)
French (fr)
Other versions
EP1546176A2 (en
Inventor
Alan Barrett
Monica Mcarthur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of EP1546176A2 publication Critical patent/EP1546176A2/en
Publication of EP1546176A4 publication Critical patent/EP1546176A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
EP03765574A 2002-07-19 2003-07-11 Methods and compositions concerning altered yellow fever virus strains Withdrawn EP1546176A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39744002P 2002-07-19 2002-07-19
US397440P 2002-07-19
PCT/US2003/022001 WO2004009764A2 (en) 2002-07-19 2003-07-11 Methods and compositions concerning altered yellow fever virus strains

Publications (2)

Publication Number Publication Date
EP1546176A2 EP1546176A2 (en) 2005-06-29
EP1546176A4 true EP1546176A4 (en) 2006-01-11

Family

ID=30771061

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03765574A Withdrawn EP1546176A4 (en) 2002-07-19 2003-07-11 Methods and compositions concerning altered yellow fever virus strains

Country Status (3)

Country Link
EP (1) EP1546176A4 (en)
AU (1) AU2003256532A1 (en)
WO (1) WO2004009764A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012001548B1 (en) 2009-07-31 2020-03-17 Ge Healthcare Bio-Sciences Corp. TYPE OF MODIFIED YELLOW FEVER VIRUS, VACCINE, NUCLEIC ACID MOLECULE, AND, METHOD TO PRODUCE A VACCINE
AR079970A1 (en) * 2010-07-23 2012-02-29 Xcellerex Inc HIGH PERFORMANCE VIRUSES OF THE YELLOW FEVER VIRUS WITH INCREASED PROPAGATION IN THE CELLS
CA2836501A1 (en) 2011-07-12 2013-01-17 Gwong-Jen J. Chang Identification of a west nile virus cd4 t cell epitope and use thereof
WO2013138670A1 (en) * 2012-03-15 2013-09-19 Icahn School Of Medicine At Mount Sinai Yellow fever virus ns5 mutants as flavivirus vaccine candidates

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037911A1 (en) * 1997-02-28 1998-09-03 Oravax, Inc. Chimeric flavivirus vaccines
EP0877086A2 (en) * 1997-04-11 1998-11-11 Fundacao Oswaldo Cruz (Fiocruz) Recombinant YF virus vaccines recovered from the infectious cDNA

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037911A1 (en) * 1997-02-28 1998-09-03 Oravax, Inc. Chimeric flavivirus vaccines
EP0877086A2 (en) * 1997-04-11 1998-11-11 Fundacao Oswaldo Cruz (Fiocruz) Recombinant YF virus vaccines recovered from the infectious cDNA

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL-SVA 4 March 2000 (2000-03-04), retrieved from EBI Database accession no. U17067.1 *
DUARTE DOS SANTOS ET AL: "Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213", VIRUS RESEARCH, AMSTERDAM, NL, vol. 35, January 1995 (1995-01-01), pages 35 - 41, XP002107898, ISSN: 0168-1702 *
HAHN C S ET AL: "Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. APR 1987, vol. 84, no. 7, April 1987 (1987-04-01), pages 2019 - 2023, XP002352447, ISSN: 0027-8424 *
MCARTHUR M A ET AL: "Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus", VIRUS RESEARCH, AMSTERDAM, NL, vol. 110, no. 1-2, June 2005 (2005-06-01), pages 65 - 71, XP004850932, ISSN: 0168-1702 *
MCARTHUR MONICA A ET AL: "Molecular characterization of a hamster viscerotropic strain of yellow fever virus.", JOURNAL OF VIROLOGY. JAN 2003, vol. 77, no. 2, January 2003 (2003-01-01), pages 1462 - 1468, XP002353178, ISSN: 0022-538X *
MUTEBI J P ET AL: "Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa.", JOURNAL OF VIROLOGY. AUG 2001, vol. 75, no. 15, August 2001 (2001-08-01), pages 6999 - 7008, XP002353179, ISSN: 0022-538X *

Also Published As

Publication number Publication date
EP1546176A2 (en) 2005-06-29
AU2003256532A1 (en) 2004-02-09
WO2004009764A2 (en) 2004-01-29
AU2003256532A8 (en) 2004-02-09
WO2004009764A3 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
EP2366803B8 (en) Compositions and methods for detecting west nile virus
EP1539180A4 (en) Compounds, compositions, and methods
AU2003236527A8 (en) Compounds, compositions, and methods
AU2003265242A8 (en) Compounds, compositions, and methods
EP1420829A4 (en) Immunomodulatory compositions, formulations, and methods for use thereof
AU2003270015A8 (en) Compounds, compositions, and methods
HUS1500047I1 (en) Vaccine against the nile fever virus
AU2003299612A8 (en) Compounds, compositions and methods
IL164581A0 (en) Compounds, compositions and methods
IL167936A0 (en) Compounds, compositions,and methods
AU2003256805A8 (en) Compounds compositions and methods
AP2005003316A0 (en) Methods and compositions for immunization against HIV
AU2002307971A1 (en) Vaccine against the nile fever virus
AU2003290507A8 (en) Compounds, compositions and methods
AU2003277079A8 (en) Compounds, compositions, and methods
AU2003297079A8 (en) Anti-filming materials, compositions and methods
EP1670893A4 (en) Immunogenic hiv compositions and related methods
AU2003256532A8 (en) Methods and compositions concerning altered yellow fever virus strains
EP1583557A4 (en) Vaccine compositions and methods
AU2003267169A8 (en) Compounds, compositions and methods
AU2003300031A8 (en) Compounds, compositions, and methods
AU2003275069A8 (en) Compositions and methods for preventing infection
GB0207224D0 (en) Tenascin-W compositions and uses thereof
AU2003245524A8 (en) Cryosurgery compositions and methods
AU2002359869A8 (en) Pak5-related compositions and methods

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050217

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20051128

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070201